期刊文献+

注射用卡络磺钠和二乙酰氨乙酸乙二胺与木糖醇注射液配伍稳定性研究 被引量:3

Compatibility of Carbazochrome Sodium Sulfonate and Ethylenediamine Diaceturate with Xylitol lnjection
下载PDF
导出
摘要 目的考察注射用卡络磺钠和注射用二乙酰氨乙酸乙二胺分别与木糖醇注射液的配伍稳定性。方法采用HPLC,测定25℃和35℃条件下静置10h内注射用卡络磺钠和注射用二乙酰氨乙酸乙二胺与5%木糖醇注射液配伍后的含量变化,比较配伍前后外观、pH的变化。结果在25℃和35℃下配伍10h内卡络磺钠含量>97.8%、二乙酰氨乙酸乙二胺含量>98.1%,外观和配伍液pH值无明显变化。结论注射用卡络磺钠、注射用二乙酰氨乙酸乙二胺与5%木糖醇注射液10h内配伍稳定。 OBJECTIVE To study the compatibility of carbazochrome sodium sulfonate and ethylenediamine diaceturate with 5 % xylitol injection. METHODS Carbazochrome sodium sulfonate and ethylenediamine diacetu- rate were mixed in 5 % xylitol injection. The content of carbazochrome sodium sulfonate and ethylenediamine di- aceturate was determined by HPLC method, and pH values of the solution was measured, and appearance of the solution was observed within 10h at 25℃ and 35℃. RESULTS Compared with initial level, the content of car- bazochrome sodium sulfonate in 5 % xylitol injection is more than 97.8 %, and the content of ethylenediamine di- aceturate solution is more than 98.1%. The appearance and pH values have no apparent changes. CONCLUSION Carbazochrome sodium sulfonate and ethylenediamine diaceturate are stable in 5 % xylitol injection within 10h at 25℃ and 35℃ .
出处 《海峡药学》 2012年第6期12-14,共3页 Strait Pharmaceutical Journal
基金 上海市嘉定区卫生局青年科研基金(编号:QNKYJJ-2009-12-1)
关键词 卡络磺钠 二乙酰氨乙酸乙二胺 5%木糖醇注射液 配伍稳定性 高效液相色谱法 Reduced glutathione Ozagrel 5 % Xylitol injection Compatibility HPLC
  • 相关文献

参考文献4

二级参考文献12

共引文献16

同被引文献27

  • 1周水根,刘放.反相高效液相色谱法测定注射用卡络磺钠注射液的含量和有关物质[J].海峡药学,2007,19(10):34-36. 被引量:8
  • 2Hussein AA,Halkes CM,SociéG,et al.Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia:a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation[J].Biol Blood Marrow Transplant,2014,20(9):1448-1450.
  • 3Tichelli A,Marsh JC.Treatment of aplastic anaemia in elderly patients aged>60 years[J].Bone Marrow Transplant,2013,48(2):180-182.
  • 4Shin SH,Lee SE,Lee JW.Recent advances in treatment of aplastic anemia[J].Korean J Intern Med,2014,29(6):713-726.
  • 5Keeli SA,Willke A,Tamer GS,et al.Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods[J].APMIS,2014,122(5):412-417.
  • 6Laishram S,Anandan S,Devi BY,et al.Determination of synergy between sulbactam,meropenem and colistin in carbapenemresistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance[J].J Chemother,2015,2:1973947815Y0000000079.
  • 7Shortt J,Hsu AK,Johnstone RW.Thalidomide-analogue biology:immunological,molecular and epigenetic targets in cancer therapy[J].Oncogene,2013,32(36):4191-4202.
  • 8宋卫中,左咏军,刘蔚.二乙酰氨乙酸乙二胺氯化钠注射液质量标准研究[J].中国实用医药,2008,3(15):88-89. 被引量:2
  • 9李文玉,李虎将.HPLC法测定维生素C制剂[J].中国药事,2008,22(9):810-812. 被引量:10
  • 10张昉,高蓉.维生素C检测方法研究进展[J].中国卫生检验杂志,2009,19(2):457-460. 被引量:30

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部